Ameritas Investment Partners, Inc. Sorrento Therapeutics, Inc. Transaction History

Ameritas Investment Partners, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$0.74 - $1.83 $6,213 - $15,364	8,396 Added 29.44%	36,911 $32,000
Q2 2022 Aug 12, 2022	BUY	$1.24 - $2.33 $6,728 - $12,642	5,426 Added 23.5%	28,515 $57,000
Q4 2021 Feb 11, 2022	BUY	$4.65 - $7.23 $9,871 - $15,349	2,123 Added 10.13%	23,089 $107,000
Q4 2020 Feb 12, 2021	BUY	$5.76 - $11.95 $12,119 - $25,142	2,104 Added 11.15%	20,966 $143,000
Q3 2020 Nov 13, 2020	BUY	$6.17 - $18.82 $20,799 - $63,442	3,371 Added 21.76%	18,862 $210,000
Q2 2020 Aug 05, 2020	BUY	$1.73 - $6.76 $10,407 - $40,668	6,016 Added 63.49%	15,491 $97,000
Q2 2019 Aug 14, 2019	BUY	$2.67 - $4.38 $5,954 - $9,767	2,230 Added 30.78%	9,475 $25,000
Q2 2018 Aug 13, 2018	BUY	$4.75 - $8.0 $34,413 - $57,960	7,245 New	7,245 $52,000

5.47M

Ticker SRNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 449,952,000
Market Cap $148M
Description
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...

Get notified when there are updates to the investment portfolio of Ameritas Investment Partners, Inc., based on Form 13F filings with the SEC.

Stay updated on Ameritas Investment Partners, Inc. with notifications on news.